Аннотация
The amplification factor of dihydropyridine (DHP)/ryanodine receptors
was defined as the amount of Ca2+ released from the sarcoplasmic
reticulum (SR) relative to the influx of Ca2+ through L-type Ca2+
channels in rat ventricular myocytes. The amplification factor showed
steep voltage dependence at potentials negative to -10 mV but was
less dependent on voltage at potentials positive to this value. In
cells dialyzed with 0.2 mM cAMP in addition to 2 mM fura 2, the Ca2+-channel
agonist (-)-BAY K 8644 enhanced Ca2+-channel current (ICa), shifted
the activation curve by -10 mV, and significantly delayed its inactivation.
Surprisingly, BAY K 8644 reduced the amplification factor by 50\%
at all potentials, even though the caffeine-releasable Ca2+ stores
were mostly intact at holding potentials of -90 mV. In contrast,
brief elevation of extracellular Ca2+ activity from 2 to 10 mM enhanced
both ICa and intracellular Ca2+ transients in the absence or presence
of BAY K 8644 but had no significant effect on the amplification
factor. BAY K 8644 abolished the direct dependence of the rate of
inactivation of ICa on the release of Ca2+ from the SR. These findings
suggest that the gain of the Ca2+-induced Ca2+ release in cardiac
myocytes is regulated by the gating kinetics of cardiac L-type Ca2+
channels via local exchange of Ca2+ signals between DHP and ryanodine
receptors and that BAY K 8644 suppresses the amplification factor
through attenuation of the Ca2+-dependent inactivation of Ca2+ channels.
- 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-,
- 3-pyridinecarboxylic
- acid,
- agonists,
- animals;
- calcium
- calcium,
- channel
- channel,
- channels,
- concentration;
- conductivity;
- cytology/metabolism;
- drug
- effects/metabolism
- effects/physiology;
- effects;
- electric
- ester,
- extracellular
- heart
- l-type;
- metabolism;
- methyl
- myocardium,
- osmolar
- pharmacology;
- physiology;
- rats;
- receptor
- release
- reticulum,
- ryanodine
- sarcoplasmic
- signaling,
- space,
- ventricles;
Пользователи данного ресурса
Пожалуйста,
войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)